Icon
+91 94997 68112
Login Register

CELESTONE SOLUSPAN (nda014602)- (3MG/ML;EQ 3MG BASE/ML)

BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE ORGANON
3MG/ML;EQ 3MG BASE/ML
No No
Expired Expired
None None
None No
When oral therapy is not feasible, the intramuscular use of CELESTONE® SOLUSPAN® Injectable Suspension is indicated as follows: Allergic states, Dermatologic Diseases, Endocrine disorders, Gastrointestinal diseases, Hematologic Disorders, Neoplastic diseases, Nervous system, Ophthalmic diseases, Renal diseases, Respiratory diseases, Rheumatic disorders, etc..
2 0 1
Total Other Developers 13
Drugs with Suitability No
3MG/ML;EQ 3MG BASE/ML ** ** - 1 -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** ******** ******, ***. *********** **** ***** *****, ********, **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.